TULIPIFERA STRATEGIES

Lobbying for TREATMENT ADVOCACY CENTER · Advocacy, education, and research related to eliminating barriers to the treatment of SMI.

Filing Registration

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 1, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Virginia

Lobbying activity 1

Health Issues

Issues related to eliminating barriers to treatment of severe mental illness, including the Medicaid IMD exclusion.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.